IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Leerink Partners (70)
- Piper Jaffray (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (14)
Jefferies
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 24 | Bold Eagle Acqu | Finance | 10 | 25 | UBS | JEFF | 49.4% | 0% | |||
| Sep 26 | BioAge Labs Inc | Health Care | 18 | 11 | GS | MS | JEFF | 42% | 1.7% | ||
| Sep 13 | MBX Biosciences | Health Care | 16 | 10 | JPM | JEFF | GGNH | 17.9% | 47.8% | ||
| Sep 13 | Zenas BioPharma | Health Care | 17 | 13 | MS | JEFF | CITI | 14.6% | 6.8% | ||
| Jul 19 | Artiva Biothera | Health Care | 12 | 13 | JEFF | COWN | CNTR | 4.6% | 0% | ||
| Jun 12 | Perceptive Capi | Finance | 10 | 7 | JEFF | 25.5% | 0.5% | ||||
| Jun 7 | Rapport Therape | Health Care | 17 | 8 | GS | JEFF | Stifel | 22.2% | 22.4% | ||
| May 9 | Silvaco Group, | Technology | 19 | 6 | JEFF | COWN | 63.9% | 4.2% | |||
| Apr 25 | Marex Group plc | Finance | 19 | 15 | BRCL | GS | JEFF | 47.2% | -1.1% | ||
| Apr 25 | Loar Holdings, | Basic Industries | 28 | 11 | JEFF | MS | CITI | 63.3% | 74.3% | ||
| Feb 9 | Metagenomi, Inc | Health Care | 15 | 6 | JPM | JEFF | WLFG | 43.7% | -31.3% | ||
| Feb 2 | Alto Neuroscien | Health Care | 16 | 8 | JEFF | Stifel | WB | 28.4% | 29.4% | ||
| Jan 26 | BrightSpring He | Health Care | 13 | 53 | GS | KKR | JEFF | 46.7% | -15.4% | ||
| Jan 26 | ArriVent BioPha | Health Care | 18 | 9 | GS | JEFF | CITI | 20.5% | 11.1% | ||
*
Lead manager or one of top three managers in an underwriting team.